MOLLY FRANKE: Open Payments
NPI 1306823281 · OTTUMWA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 49 payments from 10 companies in 2025. Trend: 2023 $651 · 2024 $780 · 2025 $1,010
Food & beverage: $835Education: $175
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $293 |
| Novartis Pharmaceuticals Corporation | 9 | $234 |
| E.R. Squibb & Sons, L.L.C. | 12 | $175 |
| ABBVIE INC. | 5 | $86 |
| UCB, Inc. | 2 | $63 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: TREMFYA, Sotyktu, Rhapsido, COSENTYX, SKYRIZI, Bimzelx, Zoryve, ILUMYA.
Industry payments across IA — which companies pay providers there.
